Axonal common peroneal nerve palsy and delayed proximal motor radial conduction block following infliximab treatment.
Argyriou
Andreas A
AA
Makridou
Alexandra
A
Karanasios
Panagiotis
P
Makris
Nicolaos
N
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy; D001369:Axons; D004576:Electromyography; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000235:genetics; D000069285:Infliximab; D009431:Neural Conduction; D010243:Paralysis / Q000139:chemically induced* / Q000503:physiopathology; D020427:Peroneal Neuropathies / Q000139:chemically induced*; D020425:Radial Neuropathy / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D000069285:Infliximab